HCAT vs CTEV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

HCAT

43.2
AI Score
VS
HCAT Wins

CTEV

29.2
AI Score

Investment Advisor Scores

HCAT

43score
Recommendation
HOLD

CTEV

29score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric HCAT CTEV Winner
Forward P/E 10 3.9108 CTEV
PEG Ratio 0 0 Tie
Revenue Growth -26.3% 9.1% CTEV
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 43.2/100 29.2/100 HCAT
Profit Margin -74.2% -27.1% CTEV
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY HCAT

Relative Price Performance (Last 90 Days)

HCAT 1M: -21.8% · 3M: -26.5% CTEV 1M: +12.4% · 3M: -29.4%

Current Technical Phase

HCAT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.3%), weak momentum, RSI 35

RSI (14): 34.5 · Price: $1.36

CTEV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.4 · Price: $26.90

Fundamentals Snapshot

Metric HCAT CTEV
Market Cap — —
Forward P/E -60.4 3.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.3% 0.1%
Gross Margin 0.5% 0.7%
Operating Margin -0.1% 0.1%
EPS -2.78 -16.41
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HCAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.